UBS Group Issues Pessimistic Forecast for Braskem (NYSE:BAK) Stock Price

Braskem logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • UBS cut Braskem’s price target from $1.50 to $0.75 and maintained a “sell” rating, implying 11.76% downside from the prior close.
  • Analyst sentiment is broadly negative: MarketBeat reports a “Strong Sell” consensus, with five sell ratings and three hold ratings and a consensus target of $2.41.
  • Braskem reported a quarterly loss of $0.52 per share, missing estimates of $0.02, despite revenue of $3.78 billion exceeding forecasts; shares traded at $0.85.
  • Five stocks we like better than Braskem.

Braskem (NYSE:BAK - Get Free Report) had its price target cut by research analysts at UBS Group from $1.50 to $0.75 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a "sell" rating on the stock. UBS Group's price target indicates a potential downside of 11.76% from the company's previous close.

Several other research analysts have also commented on BAK. Weiss Ratings reiterated a "sell (e+)" rating on shares of Braskem in a report on Thursday, October 15th. Wall Street Zen upgraded Braskem to a "hold" rating in a report on Saturday, October 17th. Finally, HSBC cut Braskem from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $6.50 to $1.50 in a research report on Monday, September 28th. Three analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Strong Sell" and a consensus target price of $2.41.

Get Our Latest Analysis on BAK

Braskem Stock Down 1.4%

Shares of BAK traded down $0.01 during mid-day trading on Thursday, hitting $0.85. 237,526 shares of the company traded hands, compared to its average volume of 2,419,414. Braskem has a 1-year low of $0.74 and a 1-year high of $5.39. The business has a 50 day moving average of $1.50 and a 200 day moving average of $2.87. The company has a market capitalization of $338.81 million, a PE ratio of -0.29 and a beta of 1.68.

Braskem (NYSE:BAK - Get Free Report) last released its quarterly earnings data on Friday, November 13th. The company reported ($0.52) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.54). Braskem had a negative return on equity of 45.63% and a negative net margin of 8.40%. The business had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.64 billion. As a group, research analysts expect that Braskem will post -0.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Braskem

Institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. raised its stake in shares of Braskem by 1,729.5% in the third quarter. Goldman Sachs Group Inc. now owns 931,022 shares of the company's stock valued at $1,350,000 after purchasing an additional 880,133 shares in the last quarter. Marshall Wace LLP lifted its stake in shares of Braskem by 93.6% during the third quarter. Marshall Wace LLP now owns 3,908,760 shares of the company's stock valued at $5,668,000 after acquiring an additional 1,889,378 shares during the period. Private Advisor Group LLC acquired a new position in Braskem in the third quarter valued at approximately $156,000. Ramsey Quantitative Systems boosted its position in shares of Braskem by 24.7% in the 3rd quarter. Ramsey Quantitative Systems now owns 79,000 shares of the company's stock worth $115,000 after purchasing an additional 15,627 shares during the last quarter. Finally, SBI Securities Co. Ltd. grew its position in shares of Braskem by 393.2% during the 3rd quarter. SBI Securities Co. Ltd. now owns 25,105 shares of the company's stock worth $36,000 after buying an additional 20,015 shares during the period.

Braskem Company Profile

(Get Free Report)

Braskem is a Brazilian petrochemical company that produces thermoplastic resins and basic petrochemicals used in packaging, construction, automotive manufacturing, consumer goods and other industries. Its products include polyethylene, polypropylene and polyvinyl chloride, as well as chemical building blocks such as ethylene and propylene. The company also makes bio-based plastics, including polyethylene produced from sugarcane-derived ethanol and marketed under its I'm green brand. These materials are designed to serve applications similar to those of conventional plastics.

Recommended Stories

Analyst Recommendations for Braskem (NYSE:BAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Braskem Right Now?

Before you consider Braskem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.

While Braskem currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines